Startups

Senior Scientist I, Drug Product & Device Development (Temporary)

Vir · San Francisco, California, United States · On-site

← All jobs
About Vir

Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. Backed by SoftBank VF.

About the role

Vir Biotechnology is looking for an accomplished Temporary Senior Scientist I (12+ month contract to start) to help advance our Drug Product and Device Development group. In this impactful role, you will take on technical leadership for the development of both liquid and lyophilized formulations across multiple biologic modalities, including support for clinical-stage process development and manufacturing initiatives.

What they're looking for

  • PhD with 5+ years , Master’s with 8+ years’ or Bachelor’s with 10+ years’ experience, in Biosciences, Pharmaceutical Technology, Biochemistry, Chemistry, Chemical Engineering, or a related discipline
  • Demonstrated expertise in formulation and drug product development for monoclonal antibodies and biologics required, hands-on experience with lyophilization strongly preferred
  • Proficiency in experimental design (DoE), data analysis, and use of statistical programs for formulation screening and optimization
  • Strong working knowledge of analytical methods supporting formulation assessments
  • Possess a solid understanding of pharmaceutical development, particularly as related to biological drug development
  • Experience authoring development reports, batch records, SOPs, regulatory filings, or other documents
More about this role

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.

Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Vir Biotechnology is looking for an accomplished Temporary Senior Scientist I (12+ month contract to start) to help advance our Drug Product and Device Development group. In this impactful role, you will take on technical leadership for the development of both liquid and lyophilized formulations...

Read the full posting on Vir's site ↗

Technical Operations

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.